●Dendritic cells as therapeutic vaccines against cancer. Banchereau, J. & Palucka, A. K. Nature Reviews Immunology April (2005)

●New York draws fire over case of drug-resistant HIV. Check, E. Nature 24 February (2005)

●Activists angry at fallout from AIDS drug trial allegations. Check, E. Nature Medicine March (2005)

●Immunosuppressive networks in the tumour environment and their therapeutic relevance. Zou, W. Nature Reviews Cancer April (2005)

●Regulatory T-cell therapy: is it ready for the clinic? Bluestone, J. A. Nature Reviews Immunology April (2005)

●Vioxx may go back on sale after scraping past FDA panel. Wadman, M. Nature 25 February (2005)

●Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Hawrylowicz, C. M. & O'Garra, A. Nature Reviews Immunology April (2005)

●Regulation and biosynthesis of carbapenem antibiotics in bacteria. Coulthurst, S. J., Barnard, A. M. L. & Salmond, G. P. C. Nature Reviews Microbiology April (2005)

●Towards safe, non-viral therapeutic gene expression in humans. Glover, D. J., Lipps, H. J. & Jans, D. A. Nature Reviews Genetics April (2005)

●Nuclear factor-κB inhibitor as a sensitizer to anticancer drugs. Nakanishi, C. & Toi, M. Nature Reviews Cancer April (2005)

●Gene-therapy trials to restart following cancer risk review. Check, E. Nature 10 March (2005)

●Chemical approaches to the discovery and development of cancer therapies. Neidle, S. & Thurston, D. E. Nature Reviews Cancer April (2005)

●Antiaging drug trials compel creative testing methods. Marris, E. Nature Medicine March (2005)

●Tumour stem cells and drug resistance. Dean, M., Fojo, T. & Bates, S. Nature Reviews Cancer April (2005)

●Statins – a cure-all for the brain? Menge, T., Hartung, H. -P. & Stüve, O. Nature Reviews Neuroscience April (2005)